ATE234619T1 - Verwendung von spiramyeine in von h.pylori verursachten magen und darm beschwerden - Google Patents

Verwendung von spiramyeine in von h.pylori verursachten magen und darm beschwerden

Info

Publication number: ATE234619T1
Authority: AT; Austria
Prior art keywords: pct; spiramycin; spiramyone; pylori; stomach
Prior art date: 1994-04-25

Application number

AT95918047T

Other languages

English (en)

Inventor

Erik T Forfang

Sven-Erik Larssen

Original Assignee

Aventis Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-04-25

Filing date

1995-04-24

Publication date

2003-04-15

1995-04-24 Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa

2003-04-15 Application granted granted Critical

2003-04-15 Publication of ATE234619T1 publication Critical patent/ATE234619T1/de

Links

230000000968 intestinal effect Effects 0.000 title 1
210000002784 stomach Anatomy 0.000 title 1
ACTOXUHEUCPTEW-BWHGAVFKSA-N 2-[(4r,5s,6s,7r,9r,10r,11e,13e,16r)-6-[(2s,3r,4r,5s,6r)-5-[(2s,4r,5s,6s)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(2s,5s,6r)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-2-o Chemical compound O([C@H]1/C=C/C=C/C[C@@H](C)OC(=O)C[C@@H](O)[C@@H]([C@H]([C@@H](CC=O)C[C@H]1C)O[C@H]1[C@@H]([C@H]([C@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@](C)(O)C2)[C@@H](C)O1)N(C)C)O)OC)[C@@H]1CC[C@H](N(C)C)[C@@H](C)O1 ACTOXUHEUCPTEW-BWHGAVFKSA-N 0.000 abstract 4
239000004187 Spiramycin Substances 0.000 abstract 4
229960001294 spiramycin Drugs 0.000 abstract 4
229930191512 spiramycin Natural products 0.000 abstract 4
235000019372 spiramycin Nutrition 0.000 abstract 4
VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 abstract 2
229960000282 metronidazole Drugs 0.000 abstract 2
241000589989 Helicobacter Species 0.000 abstract 1
239000003699 antiulcer agent Substances 0.000 abstract 1
XAUTYMZTJWXZHZ-IGUOPLJTSA-K bismuth;(e)-1-n'-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-1-n-methyl-2-nitroethene-1,1-diamine;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Bi+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-][N+](=O)\C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 XAUTYMZTJWXZHZ-IGUOPLJTSA-K 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
208000035475 disorder Diseases 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Saccharide Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

AT95918047T 1994-04-25 1995-04-24 Verwendung von spiramyeine in von h.pylori verursachten magen und darm beschwerden ATE234619T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9404952A FR2718965B1 (fr)	1994-04-25	1994-04-25	Nouvelle application thérapeutique de la spiramycine.
PCT/FR1995/000533 WO1995028943A1 (fr)	1994-04-25	1995-04-24	UTILISATION DE LA SPIRAMYCINE DANS DES DESORDRES GASTROINTESTINAUX DUS A $i(H. PYROLI)

Publications (1)

Publication Number	Publication Date
ATE234619T1 true ATE234619T1 (de)	2003-04-15

Family

ID=9462476

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT95918047T ATE234619T1 (de)	1994-04-25	1995-04-24	Verwendung von spiramyeine in von h.pylori verursachten magen und darm beschwerden

Country Status (16)

Country	Link
US (1)	US6162792A (de)
EP (1)	EP0758245B1 (de)
JP (2)	JP3937448B2 (de)
KR (1)	KR970702054A (de)
CN (1)	CN1147204A (de)
AT (1)	ATE234619T1 (de)
AU (1)	AU2412795A (de)
BR (1)	BR9507848A (de)
CA (1)	CA2188697A1 (de)
DE (1)	DE69529981T2 (de)
DK (1)	DK0758245T3 (de)
ES (1)	ES2194907T3 (de)
FR (1)	FR2718965B1 (de)
NO (1)	NO311285B1 (de)
PT (1)	PT758245E (de)
WO (1)	WO1995028943A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IN190017B (de)	1999-01-25	2003-05-31	Panacea Biotech Ltd
US6576625B2 (en)	2001-03-16	2003-06-10	Panacea Biotic Limited	Targeted vesicular constructs for cytoprotection and treatment of H. pylori infections

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0375068A1 (de) *	1988-12-23	1990-06-27	Gist-Brocades N.V.	Mischungen von Bismuth-Verbindungen und Tetracyclinen

1994
- 1994-04-25 FR FR9404952A patent/FR2718965B1/fr not_active Expired - Lifetime
1995
- 1995-04-24 AU AU24127/95A patent/AU2412795A/en not_active Abandoned
- 1995-04-24 AT AT95918047T patent/ATE234619T1/de active
- 1995-04-24 KR KR1019960705982A patent/KR970702054A/ko not_active Withdrawn
- 1995-04-24 WO PCT/FR1995/000533 patent/WO1995028943A1/fr not_active Ceased
- 1995-04-24 CN CN95192781A patent/CN1147204A/zh active Pending
- 1995-04-24 DE DE69529981T patent/DE69529981T2/de not_active Expired - Lifetime
- 1995-04-24 ES ES95918047T patent/ES2194907T3/es not_active Expired - Lifetime
- 1995-04-24 DK DK95918047T patent/DK0758245T3/da active
- 1995-04-24 US US08/727,466 patent/US6162792A/en not_active Expired - Lifetime
- 1995-04-24 PT PT95918047T patent/PT758245E/pt unknown
- 1995-04-24 BR BR9507848A patent/BR9507848A/pt not_active Application Discontinuation
- 1995-04-24 JP JP52740895A patent/JP3937448B2/ja not_active Expired - Lifetime
- 1995-04-24 CA CA002188697A patent/CA2188697A1/fr not_active Abandoned
- 1995-04-24 EP EP95918047A patent/EP0758245B1/de not_active Expired - Lifetime
1996
- 1996-10-07 NO NO19964252A patent/NO311285B1/no not_active IP Right Cessation
2007
- 2007-01-12 JP JP2007004854A patent/JP2007091761A/ja active Pending

Also Published As

Publication number	Publication date
BR9507848A (pt)	1997-09-16
PT758245E (pt)	2003-08-29
JP2007091761A (ja)	2007-04-12
JP3937448B2 (ja)	2007-06-27
NO964252L (no)	1996-10-07
US6162792A (en)	2000-12-19
DE69529981D1 (de)	2003-04-24
KR970702054A (ko)	1997-05-13
CA2188697A1 (fr)	1995-11-02
NO311285B1 (no)	2001-11-12
AU2412795A (en)	1995-11-16
EP0758245A1 (de)	1997-02-19
JPH09512262A (ja)	1997-12-09
ES2194907T3 (es)	2003-12-01
FR2718965B1 (fr)	1996-05-24
DK0758245T3 (da)	2003-07-07
WO1995028943A1 (fr)	1995-11-02
DE69529981T2 (de)	2003-12-04
FR2718965A1 (fr)	1995-10-27
NO964252D0 (no)	1996-10-07
EP0758245B1 (de)	2003-03-19
CN1147204A (zh)	1997-04-09

Similar Documents

Publication	Publication Date	Title
DK0706378T3 (da)	2003-05-05	Ny farmaceutisk formulering.
IL130931A0 (en)	2001-01-28	Small molecules useful in the treatment of inflammatory disease
NO976048L (no)	1998-02-23	Farmasöytiske og diett formuleringer for profylakse og behandling av mave- og tarmforstyrrelser
ATE269846T1 (de)	2004-07-15	N-substituierte aminotetraline als neuropeptid y y5 rezeptor-liganden und ihre anwendung zur behandlung von fettleibigkeit und anderen erkrankungen
IL112664A0 (en)	1995-05-26	4-amino derivatives of mycophenolic acid, their preparation and pharmaceutical compositions containing them
DE69518767D1 (de)	2000-10-12	Ondasetronhaltige oral anzuwendende arzneimittel
DE69532580D1 (de)	2004-03-25	Neue antagonistische verbindungen
ATE141511T1 (de)	1996-09-15	Verwendung eines bakteriozin antibiotischen agenten zur herstellung eines arzneimittels zur behandlung von magenverstimmungen, die durch helicobacter pylori verursacht werden.
BR9407748A (pt)	1997-11-11	Formulação farmacéutica processo para preparação da mesma e processo para a prevenção e/ou o tratamento de neurodegeneração ou para a obtenção de um efeito anti-convulsivo ou sedação em um paciente
ZA953537B (en)	1995-11-06	Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration
IL112667A (en)	2000-07-16	6-substituted derivatives of mycophenolic acid their preparation and pharmaceutical compositions containing them
ATE214929T1 (de)	2002-04-15	Verwendung von 7-(2-oxa-5,8-diazabicyclo 4.3.0)non-8-yl)-chinoloncarbonsäure- und - naphthyridoncarbonsäure-derivaten zur herstellung eines arzneimittels zur therapie von helicobacter-pylori-infektionen und den damit assoziierten gastroduodenalen erkrankungen
BR9813318A (pt)	2000-08-22	Processo de tratamento de tumores e degeneração macular em paciente humano ou veterinário, composição farmacêutica para tratamento de tumores e degeneração macular em um paciente humano ou veterinário
SE9502219D0 (sv)	1995-06-19	Novel medical use
FR2731907B1 (fr)	1997-06-20	Composition dermatologique et/ou cosmetique depigmentante et utilisation dans une methode cosmetique
AU1579688A (en)	1988-11-02	Bisphenylalkylpiperazine derivatives, a method of their preparation and a pharmaceutical preparation
NZ294878A (en)	1998-10-28	Water soluble derivatives of epipodophyllotoxin and medicaments
ATE234619T1 (de)	2003-04-15	Verwendung von spiramyeine in von h.pylori verursachten magen und darm beschwerden
UA32580C2 (uk)	2001-02-15	Засіб для лікування паралітичної непрохідності кишечнику
UA39349A (uk)	2001-06-15	Спосіб лікування виразкової хвороби дванадцятипалої кишки, асоційованої з helicobacter pylori
ATE221068T1 (de)	2002-08-15	Anellierte beta-carboline

Legal Events

Date

Code

Title

Description

2003-10-15

UEP

Publication of translation of european patent specification

Ref document number: 0758245

Country of ref document: EP